BKYI - BIO-key International, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 511.52M
Enterprise Value 312.18M
Trailing P/E N/A
Forward P/E 13.81
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.08
Price/Book (mrq)1.42
Enterprise Value/Revenue 33.26
Enterprise Value/EBITDA 6-2.02

Trading Information

Stock Price History

Beta (3Y Monthly) 3.32
52-Week Change 3-55.43%
S&P500 52-Week Change 31.35%
52 Week High 32.0000
52 Week Low 30.7500
50-Day Moving Average 31.1659
200-Day Moving Average 31.1989

Share Statistics

Avg Vol (3 month) 39.13k
Avg Vol (10 day) 36.02k
Shares Outstanding 514.08M
Float 6.8M
% Held by Insiders 154.42%
% Held by Institutions 11.90%
Shares Short (Jul 31, 2019) 416.08k
Short Ratio (Jul 31, 2019) 42.83
Short % of Float (Jul 31, 2019) 40.21%
Short % of Shares Outstanding (Jul 31, 2019) 40.11%
Shares Short (prior month Jun 28, 2019) 427.77k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 212/1
Last Split Date 3Dec 29, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -167.36%
Operating Margin (ttm)-164.29%

Management Effectiveness

Return on Assets (ttm)-32.28%
Return on Equity (ttm)-64.00%

Income Statement

Revenue (ttm)3.73M
Revenue Per Share (ttm)0.27
Quarterly Revenue Growth (yoy)-2.60%
Gross Profit (ttm)-119.65k
EBITDA -6.04M
Net Income Avi to Common (ttm)-7.68M
Diluted EPS (ttm)-0.5560
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)687.02k
Total Cash Per Share (mrq)0.05
Total Debt (mrq)1.07M
Total Debt/Equity (mrq)13.20
Current Ratio (mrq)1.41
Book Value Per Share (mrq)0.56

Cash Flow Statement

Operating Cash Flow (ttm)-1.97M
Levered Free Cash Flow (ttm)212.3k